Systemic redox imbalance in neurodegeneration: How industrial metabolic disruption and colonial health legacies drive cellular dysfunction
Original framing: “New research on cellular redox reactions sheds light on the path of neurodegenerative diseases” — Phys.org
Indigenous detoxification traditions (e.g., Ayurvedic panchakarma, African herbal protocols) that address redox balance; historical parallels like the 19th-century 'disease of civilisation' debates linking diet to neural degeneration; structural causes such as lead exposure in marginalised communities or the legacy of uranium mining on Indigenous lands; marginalised perspectives from Global South researchers studying environmental epigenetics.
Low structural omission detected in mainstream coverage.
The narrative is produced by Western biomedical institutions (e.g., Phys.org, funded by NIH/NSF) for a global scientific audience, serving the pharmaceutical industry’s interest in patentable interventions over prevention. Framing ROS as a 'mystery' obscures corporate responsibility for environmental toxins and the failure of colonial health systems to address chronic disease in formerly colonised regions. This depoliticised approach prioritises lab-based solutions over systemic reforms like agrochemical regulation or Indigenous land remediation.
Marginalised communities bear disproportionate redox burdens: Black Americans have higher ALS rates due to lead exposure from redlining, while Indigenous peoples face mitochondrial damage from uranium mining (e.g., Navajo Nation). Global South researchers (e.g., in Nigeria or India) document environmental epigenetics in neurodegeneration but lack funding to publish in high-impact journals. Their insights—such as the role of aflatoxins in ALS—are sidelined in favour of Western genetic determinism.
Neurodegeneration is not a cellular anomaly but a systemic failure of industrial metabolism, colonial health legacies, and ecological rupture, where ROS serve as a biomarker of deeper imbalances.